Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Innovative Biopharmaceutical Company, Domainex, has core intellectual property rights granted for Europe
October 11th, 2008
Domainex Ltd (Domainex), an innovative biopharmaceutical company, announced the grant of European Patent No.1442134 for its Combinatorial Domain Hunting (CDH) Technology. Based in London and Cambridge, Domainex is a research company developing a pipeline of pre-clinical drugs and targets, specializing in the development of novel drug targets reached by the CDH technology. The Company is also providing its unique structural biology and chemistry services to major pharmaceutical and biotechnology firms. The vast amount of information available in the post-genomic era means that there are many highly attractive protein targets known to the...
Source: Law & Health Weekly (2008-10-11)
|
